NK cells in innate immunity

Current Opinion in Immunology

Volumn 17, Issue 1, 2005, Pages 29-35

  Hamerman, Jessica A ^a   Ogasawara, Kouetsu ^a   Lanier, Lewis L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL KILLER CELL RECEPTOR NKG2D;

CELL ACTIVATION; CELL MATURATION; CYTOLOGY; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; DENDRITIC CELL; HEPATITIS C VIRUS; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INNATE IMMUNITY; MOLECULAR RECOGNITION; NATURAL KILLER CELL; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL COMMUNICATION; DENDRITIC CELLS; HUMANS; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; SIGNAL TRANSDUCTION; VIRUS DISEASES; VIRUSES;

EID: 11844289524     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2004.11.001     Document Type: Review

References (66)

1. Lanier LL: NK cell recognition. Annu Rev Immunol 2004. DOI: 10.1146/annurev.immunol.23.021704.115526.
2. N.C. Fernandez, A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E. Maraskovsky, and L. Zitvogel Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo Nat Med 5 1999 405 411
3. Y. Yu, M. Hagihara, K. Ando, B. Gansuvd, H. Matsuzawa, T. Tsuchiya, Y. Ueda, H. Inoue, T. Hotta, and S. Kato Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells J Immunol 166 2001 1590 1600
4. G. Ferlazzo, M.L. Tsang, L. Moretta, G. Melioli, R.M. Steinman, and C. Munz Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells J Exp Med 195 2002 343 351
5. F. Gerosa, B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri Reciprocal activating interaction between natural killer cells and dendritic cells J Exp Med 195 2002 327 333
6. F. Granucci, I. Zanoni, N. Pavelka, S.L. Van Dommelen, C.E. Andoniou, F. Belardelli, M.A. Degli Esposti, and P. Ricciardi-Castagnoli A Contribution of Mouse Dendritic Cell-Derived IL-2 for NK Cell Activation J Exp Med 200 2004 287 295
7. D. Piccioli, S. Sbrana, E. Melandri, and N.M. Valiante Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells J Exp Med 195 2002 335 341
8. ••] immunity.
9. ••].
10. E. Buentke, L.C. Heffler, J.L. Wilson, R.P. Wallin, C. Lofman, B.J. Chambers, H.G. Ljunggren, and A. Scheynius Natural killer and dendritic cell contact in lesional atopic dermatitis skin-Malassezia-influenced cell interaction J Invest Dermatol 119 2002 850 857
11. •] contain the first description of NK cells in human lymph nodes.
12. •].
13. J.S. Orange, M.S. Fassett, L.A. Koopman, J.E. Boyson, and J.L. Strominger Viral evasion of natural killer cells Nat Immunol 3 2002 1006 1012
14. C.A. Biron, K.S. Byron, and J.L. Sullivan Severe herpesvirus infections in an adolescent without natural killer cells N Engl J Med 320 1989 1731 1735
15. J.F. Bukowski, B.A. Woda, S. Habu, K. Okumura, and R.M. Welsh Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo J Immunol 131 1983 1531 1538
16. A.A. Scalzo Successful control of viruses by NK cells-a balance of opposing forces? Trends Microbiol 10 2002 470 474
17. K.A. Daniels, G. Devora, W.C. Lai, C.L. O'Donnell, M. Bennett, and R.M. Welsh Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H J Exp Med 194 2001 29 44
18. S.H. Lee, S. Girard, D. Macina, M. Busa, A. Zafer, A. Belouchi, P. Gros, and S.M. Vidal Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily Nat Genet 28 2001 42 45
19. M.G. Brown, A.O. Dokun, J.W. Heusel, H.R. Smith, D.L. Beckman, E.A. Blattenberger, C.E. Dubbelde, L.R. Stone, A.A. Scalzo, and W.M. Yokoyama Vital involvement of a natural killer cell activation receptor in resistance to viral infection Science 292 2001 934 937
20. H. Sjolin, E. Tomasello, M. Mousavi-Jazi, A. Bartolazzi, K. Karre, E. Vivier, and C. Cerboni Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection J Exp Med 195 2002 825 834
21. H. Arase, E.S. Mocarski, A.E. Campbell, A.B. Hill, and L.L. Lanier Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors Science 296 2002 1323 1326
22. H.R. Smith, J.W. Heusel, I.K. Mehta, S. Kim, B.G. Dorner, O.V. Naidenko, K. Iizuka, H. Furukawa, D.L. Beckman, and J.T. Pingel Recognition of a virus-encoded ligand by a natural killer cell activation receptor Proc Natl Acad Sci USA 99 2002 8826 8831
23. V. Voigt, C.A. Forbes, J.N. Tonkin, M.A. Degli-Esposti, H.R. Smith, W.M. Yokoyama, and A.A. Scalzo Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells Proc Natl Acad Sci USA 100 2003 13483 13488 A demonstration of the in vivo relevance of the m157-Ly49H interaction, resulting in selective pressure on the virus.
24. A. Rolle, M. Mousavi-Jazi, M. Eriksson, J. Odeberg, C. Soderberg-Naucler, D. Cosman, K. Karre, and C. Cerboni Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein J Immunol 171 2003 902 908
25. C. Dunn, N.J. Chalupny, C.L. Sutherland, S. Dosch, P.V. Sivakumar, D.C. Johnson, and D. Cosman Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity J Exp Med 197 2003 1427 1439
26. J. Wu, N.J. Chalupny, T.J. Manley, S.R. Riddell, D. Cosman, and T. Spies Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein J Immunol 170 2003 4196 4200
27. S.A. Welte, C. Sinzger, S.Z. Lutz, H. Singh-Jasuja, K.L. Sampaio, U. Eknigk, H.G. Rammensee, and A. Steinle Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein Eur J Immunol 33 2003 194 203
28. M. Lodoen, K. Ogasawara, J.A. Hamerman, H. Arase, J.P. Houchins, E.S. Mocarski, and L.L. Lanier NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules J Exp Med 197 2003 1245 1253
29. A. Krmpotic, D.H. Busch, I. Bubic, F. Gebhardt, H. Hengel, M. Hasan, A.A. Scalzo, U.H. Koszinowski, and S. Jonjic MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo Nat Immunol 3 2002 529 535
30. Lodoen M, Abenes G, Umamoto S, Houchins JP, Li F, Lanier LL: The Cytomegalovirus m155 Gene Product Subverts NK cell Antiviral Protection by Disruption of H60-NKG2D Interactions. J Exp Med 2004, in press.
31. P. Pileri, Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A.J. Weiner, M. Houghton, D. Rosa, and G. Grandi Binding of hepatitis C virus to CD81 Science 282 1998 938 941
32. S. Crotta, A. Stilla, A. Wack, A. D'Andrea, S. Nuti, U. D'Oro, M. Mosca, F. Filliponi, R.M. Brunetto, and F. Bonino Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein J Exp Med 195 2002 35 41
33. C.T. Tseng, and G.R. Klimpel Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions J Exp Med 195 2002 43 49
34. ••,35] give the first hint that NK receptors affect the outcome of infection with important human viral pathogens.
35. M.P. Martin, X. Gao, J.H. Lee, G.W. Nelson, R. Detels, J.J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, and J. Trowsdale Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS Nat Genet 31 2002 429 434
36. D. Mavilio, J. Benjamin, M. Daucher, G. Lombardo, S. Kottilil, M.A. Planta, E. Marcenaro, C. Bottino, L. Moretta, and A. Moretta Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates Proc Natl Acad Sci USA 100 2003 15011 15016
37. F. Colucci, M.A. Caligiuri, and J.P. Di Santo What does it take to make a natural killer? Nat Rev Immunol 3 2003 413 425 An excellent review of NK cell ontogeny and differentiation.
38. S. Kim, K. Iizuka, H.S. Kang, A. Dokun, A.R. French, S. Greco, and W.M. Yokoyama In vivo developmental stages in murine natural killer cell maturation Nat Immunol 3 2002 523 528
39. M.J. Loza, and B. Perussia Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation? Nat Immunol 2 2001 917 924
40. K. Benlagha, T. Kyin, A. Beavis, L. Teyton, and A. Bendelac A thymic precursor to the NK T cell lineage Science 296 2002 553 555
41. S.I. Samson, O. Richard, M. Tavian, T. Ranson, C.A. Vosshenrich, F. Colucci, J. Buer, F. Grosveld, I. Godin, and J.P. Di Santo GATA-3 promotes maturation, IFN-gamma production, and liver-specific homing of NK cells Immunity 19 2003 701 711
42. M.J. Townsend, A.S. Weinmann, J.L. Matsuda, R. Salomon, P.J. Farnham, C.A. Biron, L. Gapin, and L.H. Glimcher T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells Immunity 20 2004 477 494
43. H.D. Lacorazza, Y. Miyazaki, A. Di Cristofano, A. Deblasio, C. Hedvat, J. Zhang, C. Cordon-Cardo, S. Mao, P.P. Pandolfi, and S.D. Nimer The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells Immunity 17 2002 437 449
44. A.M. Jamieson, P. Isnard, J.R. Dorfman, M.C. Coles, and D.H. Raulet Turnover and proliferation of NK cells in steady state and lymphopenic conditions J Immunol 172 2004 864 870
45. M.T. Kasaian, M.J. Whitters, L.L. Carter, L.D. Lowe, J.M. Jussif, B. Deng, K.A. Johnson, J.S. Witek, M. Senices, and R.F. Konz IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity Immunity 16 2002 559 569
46. ••] document the role of IL-15 in the homeostasis of NK cells.
47. ••].
48. J. Brady, Y. Hayakawa, M.J. Smyth, and S.L. Nutt IL-21 induces the functional maturation of murine NK cells J Immunol 172 2004 2048 2058
49. J. Parrish-Novak, S.R. Dillon, A. Nelson, A. Hammond, C. Sprecher, J.A. Gross, J. Johnston, K. Madden, W. Xu, and J. West Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function Nature 408 2000 57 63
50. S. Sivori, C. Cantoni, S. Parolini, E. Marcenaro, R. Conte, L. Moretta, and A. Moretta IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors Eur J Immunol 33 2003 3439 3447
51. J. Wu, Y. Song, Bakker ABH, S. Bauer, V. Groh, T. Spies, L.L. Lanier, and J.H. Phillips An activating receptor complex on natural killer and T cells formed by NKG2D and DAP10 Science 285 1999 730 732
52. S. Gilfillan, E.L. Ho, M. Cella, W.M. Yokoyama, and M. Colonna NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation Nat Immunol 3 2002 1150 1155
53. A. Diefenbach, E. Tomasello, M. Lucas, A.M. Jamieson, J.K. Hsia, E. Vivier, and D.H. Raulet Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D Nat Immunol 3 2002 1142 1149
54. P. Andre, R. Castriconi, M. Espeli, N. Anfossi, T. Juarez, S. Hue, H. Conway, F. Romagne, A. Dondero, and M. Nanni Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors Eur J Immunol 34 2004 961 971
55. D.B. Rosen, M. Araki, J.A. Hamerman, T. Chen, T. Yamamura, and L.L. Lanier A Structural Basis for the Association of DAP12 with Mouse, but not Human, NKG2D J Immunol 173 2004 2470 2478
56. D.D. Billadeau, J.L. Upshaw, R.A. Schoon, C.J. Dick, and P.J. Leibson NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway Nat Immunol 4 2003 557 564
57. S. Zompi, J.A. Hamerman, K. Ogasawara, E. Schweighoffer, V.L. Tybulewicz, J.P. Di Santo, L.L. Lanier, and F. Colucci NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases Nat Immunol 4 2003 565 572
58. J.A. Hamerman, K. Ogasawara, and L.L. Lanier Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor J Immunol 172 2004 2001 2005
59. •] implicate the overexpression of NKG2D ligands in autoimmune disease and suggest potential new therapeutic directions.
60. •].
61. V. Groh, J. Wu, C. Yee, and T. Spies Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation Nature 419 2002 734 738
62. E.S. Doubrovina, M.M. Doubrovin, E. Vider, R.B. Sisson, R.J. O'Reilly, B. Dupont, and Y.M. Vyas Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma J Immunol 171 2003 6891 6899
63. H.R. Salih, H. Antropius, F. Gieseke, S.Z. Lutz, L. Kanz, H.G. Rammensee, and A. Steinle Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia Blood 102 2003 1389 1396
64. P.A. Mathew, B.A. Garni-Wagner, K. Land, A. Takashima, E. Stoneman, M. Bennett, and V. Kumar Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells J Immunol 151 1993 5328 5337
65. K.M. Lee, M.E. McNerney, S.E. Stepp, P.A. Mathew, J.D. Schatzle, M. Bennett, and V. Kumar 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells J Exp Med 199 2004 1245 1254
66. R. Chen, F. Relouzat, R. Roncagalli, A. Aoukaty, R. Tan, S. Latour, and A. Veillette Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors Mol Cell Biol 24 2004 5144 5156